{"title":"AL淀粉样变性患者肾脏分期系统的验证及其与肾脏淀粉样蛋白沉积负荷的关系。","authors":"Ying Yao, Shuang Wang, Dan-Yang Li, Xiao-Juan Yu, Jia-Yi Liu, Zhi-Xiang Qiu, Fu-De Zhou, Su-Xia Wang","doi":"10.1080/0886022X.2025.2499230","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>This study evaluates the relationship between renal amyloid deposition burden in kidney biopsy and a renal staging system based on proteinuria and estimated glomerular filtration rate (eGFR) in AL amyloidosis.</p><p><strong>Methods: </strong>A total of 248 patients diagnosed <i>via</i> renal biopsy were included. The extent of amyloid deposition in glomeruli, blood vessels, and tubulointerstitium were evaluated semiquantitatively. The total amyloid load (TA) was defined by the sum of glomerular, vascular and interstitial deposits.</p><p><strong>Results: </strong>Patients were categorized into three renal stages: I, II, and III. Findings showed that scores of pathological parameters increased progressive with advancing renal stage. The median TA values were 6 (IQR 3-8) in Stage I, 7 (IQR 5-8) in Stage II, and 8 (IQR 7-11) in Stage III (<i>p</i> < 0.001). Baseline eGFR was inversely correlated with TA (<i>r</i> = -0.363, <i>p</i> < 0.001), while proteinuria showed no significant association. Cox regression analysis identified eGFR <50 mL/min/1.73 m<sup>2</sup> as an independent risk factor for renal survival (HR, 6.519; 95% CI, 3.110-13.665; <i>p</i> < 0.001), whereas proteinuria did not show such an effect.</p><p><strong>Conclusions: </strong>These findings suggest that in the renal staging system, eGFR - but not proteinuria - is significantly associated with amyloid deposition and independently affects renal survival.</p>","PeriodicalId":20839,"journal":{"name":"Renal Failure","volume":"47 1","pages":"2499230"},"PeriodicalIF":3.0000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12090301/pdf/","citationCount":"0","resultStr":"{\"title\":\"Validation of a renal staging system and its association with renal amyloid deposition burden in AL amyloidosis.\",\"authors\":\"Ying Yao, Shuang Wang, Dan-Yang Li, Xiao-Juan Yu, Jia-Yi Liu, Zhi-Xiang Qiu, Fu-De Zhou, Su-Xia Wang\",\"doi\":\"10.1080/0886022X.2025.2499230\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>This study evaluates the relationship between renal amyloid deposition burden in kidney biopsy and a renal staging system based on proteinuria and estimated glomerular filtration rate (eGFR) in AL amyloidosis.</p><p><strong>Methods: </strong>A total of 248 patients diagnosed <i>via</i> renal biopsy were included. The extent of amyloid deposition in glomeruli, blood vessels, and tubulointerstitium were evaluated semiquantitatively. The total amyloid load (TA) was defined by the sum of glomerular, vascular and interstitial deposits.</p><p><strong>Results: </strong>Patients were categorized into three renal stages: I, II, and III. Findings showed that scores of pathological parameters increased progressive with advancing renal stage. The median TA values were 6 (IQR 3-8) in Stage I, 7 (IQR 5-8) in Stage II, and 8 (IQR 7-11) in Stage III (<i>p</i> < 0.001). Baseline eGFR was inversely correlated with TA (<i>r</i> = -0.363, <i>p</i> < 0.001), while proteinuria showed no significant association. Cox regression analysis identified eGFR <50 mL/min/1.73 m<sup>2</sup> as an independent risk factor for renal survival (HR, 6.519; 95% CI, 3.110-13.665; <i>p</i> < 0.001), whereas proteinuria did not show such an effect.</p><p><strong>Conclusions: </strong>These findings suggest that in the renal staging system, eGFR - but not proteinuria - is significantly associated with amyloid deposition and independently affects renal survival.</p>\",\"PeriodicalId\":20839,\"journal\":{\"name\":\"Renal Failure\",\"volume\":\"47 1\",\"pages\":\"2499230\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12090301/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Renal Failure\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/0886022X.2025.2499230\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/5/19 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Renal Failure","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/0886022X.2025.2499230","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/19 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的:本研究评估肾活检中肾淀粉样蛋白沉积负荷与基于蛋白尿和估计肾小球滤过率(eGFR)的肾分期系统之间的关系。方法:共纳入248例经肾活检确诊的患者。对肾小球、血管和小管间质淀粉样蛋白沉积程度进行半定量评估。总淀粉样蛋白负荷(TA)由肾小球、血管和间质沉积的总和来定义。结果:患者肾分期分为I、II、III期。结果显示,随着肾期的进展,病理参数得分逐渐增加。I期TA中位值为6 (IQR 3-8), II期为7 (IQR 5-8), III期为8 (IQR 7-11) (p r = -0.363, p 2),是肾脏生存的独立危险因素(HR, 6.519;95% ci, 3.110-13.665;结论:这些发现表明,在肾脏分期系统中,eGFR(而非蛋白尿)与淀粉样蛋白沉积显著相关,并独立影响肾脏生存。
Validation of a renal staging system and its association with renal amyloid deposition burden in AL amyloidosis.
Objectives: This study evaluates the relationship between renal amyloid deposition burden in kidney biopsy and a renal staging system based on proteinuria and estimated glomerular filtration rate (eGFR) in AL amyloidosis.
Methods: A total of 248 patients diagnosed via renal biopsy were included. The extent of amyloid deposition in glomeruli, blood vessels, and tubulointerstitium were evaluated semiquantitatively. The total amyloid load (TA) was defined by the sum of glomerular, vascular and interstitial deposits.
Results: Patients were categorized into three renal stages: I, II, and III. Findings showed that scores of pathological parameters increased progressive with advancing renal stage. The median TA values were 6 (IQR 3-8) in Stage I, 7 (IQR 5-8) in Stage II, and 8 (IQR 7-11) in Stage III (p < 0.001). Baseline eGFR was inversely correlated with TA (r = -0.363, p < 0.001), while proteinuria showed no significant association. Cox regression analysis identified eGFR <50 mL/min/1.73 m2 as an independent risk factor for renal survival (HR, 6.519; 95% CI, 3.110-13.665; p < 0.001), whereas proteinuria did not show such an effect.
Conclusions: These findings suggest that in the renal staging system, eGFR - but not proteinuria - is significantly associated with amyloid deposition and independently affects renal survival.
期刊介绍:
Renal Failure primarily concentrates on acute renal injury and its consequence, but also addresses advances in the fields of chronic renal failure, hypertension, and renal transplantation. Bringing together both clinical and experimental aspects of renal failure, this publication presents timely, practical information on pathology and pathophysiology of acute renal failure; nephrotoxicity of drugs and other substances; prevention, treatment, and therapy of renal failure; renal failure in association with transplantation, hypertension, and diabetes mellitus.